These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 34423001)

  • 1. Combination of natural killer cell-based immunotherapy and irreversible electroporation for the treatment of hepatocellular carcinoma.
    Eresen A; Yang J; Scotti A; Cai K; Yaghmai V; Zhang Z
    Ann Transl Med; 2021 Jul; 9(13):1089. PubMed ID: 34423001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatment.
    Lin M; Liang S; Wang X; Liang Y; Zhang M; Chen J; Niu L; Xu K
    J Cancer Res Clin Oncol; 2017 Dec; 143(12):2607-2618. PubMed ID: 28871458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogenic Natural Killer Cell Immunotherapy Combined with Irreversible Electroporation for Stage IV Hepatocellular Carcinoma: Survival Outcome.
    Alnaggar M; Lin M; Mesmar A; Liang S; Qaid A; Xu K; Chen J; Niu L; Yin Z
    Cell Physiol Biochem; 2018; 48(5):1882-1893. PubMed ID: 30092590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An important discovery on combination of irreversible electroporation and allogeneic natural killer cell immunotherapy for unresectable pancreatic cancer.
    Lin M; Alnaggar M; Liang S; Wang X; Liang Y; Zhang M; Chen J; Niu L; Xu K
    Oncotarget; 2017 Nov; 8(60):101795-101807. PubMed ID: 29254205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of irreversible electroporation ablation combined with natural killer cells in treating locally advanced pancreatic cancer.
    Pan Q; Hu C; Fan Y; Wang Y; Li R; Hu X
    J BUON; 2020; 25(3):1643-1649. PubMed ID: 32862617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Short-Term Efficacy of Irreversible Electroporation and Allogenic Natural Killer Cell Immunotherapy Combination in the Treatment of Patients with Unresectable Primary Liver Cancer.
    Yang Y; Qin Z; Du D; Wu Y; Qiu S; Mu F; Xu K; Chen J
    Cardiovasc Intervent Radiol; 2019 Jan; 42(1):48-59. PubMed ID: 30151798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irreversible Electroporation: An Emerging Immunomodulatory Therapy on Solid Tumors.
    Zhang N; Li Z; Han X; Zhu Z; Li Z; Zhao Y; Liu Z; Lv Y
    Front Immunol; 2021; 12():811726. PubMed ID: 35069599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological effect of irreversible electroporation on hepatocellular carcinoma.
    Guo X; Du F; Liu Q; Guo Y; Wang Q; Huang W; Wang Z; Ding X; Wu Z
    BMC Cancer; 2021 Apr; 21(1):443. PubMed ID: 33882892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irreversible electroporation induces CD8
    Dai Z; Wang Z; Lei K; Liao J; Peng Z; Lin M; Liang P; Yu J; Peng S; Chen S; Kuang M
    Cancer Lett; 2021 Apr; 503():1-10. PubMed ID: 33444692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term clinical efficacy of percutaneous irreversible electroporation combined with allogeneic natural killer cell for treating metastatic pancreatic cancer.
    Lin M; Liang S; Wang X; Liang Y; Zhang M; Chen J; Niu L; Xu K
    Immunol Lett; 2017 Jun; 186():20-27. PubMed ID: 28392199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irreversible electroporation ablation overcomes tumor-associated immunosuppression to improve the efficacy of DC vaccination in a mice model of pancreatic cancer.
    Yang J; Eresen A; Shangguan J; Ma Q; Yaghmai V; Zhang Z
    Oncoimmunology; 2021 Feb; 10(1):1875638. PubMed ID: 33643692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irreversible electroporation versus radiofrequency ablation for hepatocellular carcinoma: a single centre propensity-matched comparison.
    Freeman E; Cheung W; Ferdousi S; Kavnoudias H; Majeed A; Kemp W; Roberts SK
    Scand J Gastroenterol; 2021 Aug; 56(8):942-947. PubMed ID: 34057003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irreversible Electroporation versus Radiofrequency Ablation: Comparison of Systemic Immune Responses in Patients with Hepatocellular Carcinoma.
    Sugimoto K; Kakimi K; Takeuchi H; Fujieda N; Saito K; Sato E; Sakamaki K; Moriyasu F; Itoi T
    J Vasc Interv Radiol; 2019 Jun; 30(6):845-853.e6. PubMed ID: 31126596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of NK-based immunotherapy and sorafenib against hepatocellular carcinoma.
    Yang J; Eresen A; Scotti A; Cai K; Zhang Z
    Am J Cancer Res; 2021; 11(2):337-349. PubMed ID: 33575075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adoptive transfer of TRAIL-expressing natural killer cells prevents recurrence of hepatocellular carcinoma after partial hepatectomy.
    Ohira M; Ohdan H; Mitsuta H; Ishiyama K; Tanaka Y; Igarashi Y; Asahara T
    Transplantation; 2006 Dec; 82(12):1712-9. PubMed ID: 17198265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irreversible electroporation enhances immunotherapeutic effect in the off-target tumor in a murine model of orthotopic HCC.
    Shi X; O'Neill C; Wang X; Chen Y; Yu Y; Tan M; Lv G; Li Y; Martin RC
    Am J Cancer Res; 2021; 11(6):3304-3319. PubMed ID: 34249464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electric Pulse Responsive Magnetic Nanoclusters Loaded with Indoleamine 2,3-Dioxygenase Inhibitor for Synergistic Immuno-Ablation Cancer Therapy.
    Yu B; Zhang W; Kwak K; Choi H; Kim DH
    ACS Appl Mater Interfaces; 2020 Dec; 12(49):54415-54425. PubMed ID: 33237729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial Assessment of the Efficacy of Irreversible Electroporation in the Focal Treatment of Localized Renal Cell Carcinoma With Delayed-interval Kidney Tumor Resection (Irreversible Electroporation of Kidney Tumors Before Partial Nephrectomy [IRENE] Trial-An Ablate-and-Resect Pilot Study).
    Wendler JJ; Pech M; Fischbach F; Jürgens J; Friebe B; Baumunk D; Porsch M; Blaschke S; Schindele D; Siedentopf S; Ricke J; Schostak M; Köllermann J; Liehr UB
    Urology; 2018 Apr; 114():224-232. PubMed ID: 29305201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Research progress on immunotherapy based on NK cells for hepatocellular carcinoma].
    Zhu X; Zhou Y; Zhu S
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Jan; 40(1):80-88. PubMed ID: 38246181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer cells ablation with irreversible electroporation.
    Miller L; Leor J; Rubinsky B
    Technol Cancer Res Treat; 2005 Dec; 4(6):699-705. PubMed ID: 16292891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.